Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanqi Medicinal Liquor for osteoarthritis
ChiCTR1800015405Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medicine University
- Start
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of panax notoginseng in osteoarthritis (OA), sponsored by The Second Affiliated Hospital of Zhejiang Chinese Medicine University. Primary endpoints: WOMAC score and Lequesne score. Started Dec 2017; status: recruiting.
02
Drugs
panax notoginseng
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1800015405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015405.